Many patients combine non-surgical treatments with their ongoing GLP-1 therapy to optimize results, though realistic expectations about the degree of improvement are essential
Beyond the improved glycaemia control, essential for the short term treatment of diabetes (188), different GLP-1RAs are powerful clinical tools for the management of diabetic kidney disease (DKD) (189) non-alcoholic steatohepatitis (NASH) (190), neuroinflammation (191), obesity and cardiovascular disease (192195)
doi: 10.2478/inmed-2019-0062
Fu S C, Cheuk Y C, Chiu W Y V, et al
10.1073/pnas.86.6.2040 Summary Keywords red blood cells, drug transport, blood-to-plasma ratio, pharmacokinetic, blood distribution Citation Biagiotti S, Perla E and Magnani M (2023) Drug transport by red blood cells